Literature DB >> 12789572

Ophthalmic manifestations of congenital disorder of glycosylation type 1a.

Hanne Jensen1, Susanne Kjaergaard, Flemming Klie, H U Moller.   

Abstract

PURPOSE: To present the ophthalmic manifestations of patients with congenital disorder of glycosylation type Ia (CDG-Ia) due to the frequent R141H/F119L PMM2 genotype.
METHODS: Ophthalmic records of 23 patients (age: 10 months to 20 years) were evaluated. They had had at least one ophthalmic reexamination.
RESULTS: Measurements of refractive error showed that 18 patients were myopic, two were hypermetropic, and three could not be measured. Serial measurements in 12 patients indicated a progression towards myopia of 0.80 diopters (D) per year. Congenital esotropia and delayed visual maturation (DVM) were consistent findings. Two children developed good visual acuity (VA), 16 had low vision, and five were legally blind. Pallor of the optic disc was noted in five patients. Electroretinography (ERG) performed in nine patients showed reduced rod responses, while cone responses were only slightly reduced.
CONCLUSIONS: The present study illustrates the difficulties in examining severely disabled children. Consistent ophthalmic manifestations of CDG-Ia patients due to the R141H/F119L genotype were congenital esotropia, DVM, and a reduced rod response in ERG-examined patients. The vast majority of patients had reduced VA and developed myopia. We speculate that there is a relationship between the glycosylation defect in CDG-Ia and the development of myopia. We recommend that CDG-Ia patients be followed annually by an ophthalmologist.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789572     DOI: 10.1076/opge.24.2.81.13994

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  17 in total

1.  Neurology of inherited glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Lancet Neurol       Date:  2012-05       Impact factor: 44.182

2.  Glycosylation type Ic disorder: idiopathic intracranial hypertension and retinal degeneration.

Authors:  M Y Kahook; N Mandava; J B Bateman; J A Thomas
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

3.  Retinal characteristics of the congenital disorder of glycosylation PMM2-CDG.

Authors:  Dorothy A Thompson; Ruth J Lyons; Isabelle Russell-Eggitt; Alki Liasis; Herbert Jägle; Stephanie Grünewald
Journal:  J Inherit Metab Dis       Date:  2013-02-22       Impact factor: 4.982

4.  Common variants near ABCA1 and in PMM2 are associated with primary open-angle glaucoma.

Authors:  Yuhong Chen; Ying Lin; Eranga N Vithana; Liyun Jia; Xianbo Zuo; Tien Yin Wong; Li Jia Chen; Xianjun Zhu; Pancy O S Tam; Bo Gong; Shaohong Qian; Zheng Li; Xiaoqi Liu; Baskaran Mani; Qian Luo; Celeste Guzman; Christopher K S Leung; Xiaobo Li; Wenjun Cao; Quanyao Yang; Clement C Y Tham; Yilian Cheng; Xuejun Zhang; Ningli Wang; Tin Aung; Chiea Chuen Khor; Chi Pui Pang; Xinghuai Sun; Zhenglin Yang
Journal:  Nat Genet       Date:  2014-08-31       Impact factor: 38.330

5.  Novel genetic causes for cerebral visual impairment.

Authors:  Daniëlle G M Bosch; F Nienke Boonstra; Nicole de Leeuw; Rolph Pfundt; Willy M Nillesen; Joep de Ligt; Christian Gilissen; Shalini Jhangiani; James R Lupski; Frans P M Cremers; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2015-09-09       Impact factor: 4.246

6.  A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism.

Authors:  Eva Morava; Ron A Wevers; Vincent Cantagrel; Lies H Hoefsloot; Lihadh Al-Gazali; Jeroen Schoots; Arno van Rooij; Karin Huijben; Connie M A van Ravenswaaij-Arts; Marjolein C J Jongmans; Jolanta Sykut-Cegielska; Georg F Hoffmann; Peter Bluemel; Maciej Adamowicz; Jeroen van Reeuwijk; Bobby G Ng; Jorieke E H Bergman; Hans van Bokhoven; Christian Körner; Dusica Babovic-Vuksanovic; Michel A Willemsen; Joseph G Gleeson; Ludwig Lehle; Arjan P M de Brouwer; Dirk J Lefeber
Journal:  Brain       Date:  2010-09-17       Impact factor: 13.501

7.  Cerebral visual impairment and intellectual disability caused by PGAP1 variants.

Authors:  Daniëlle G M Bosch; F Nienke Boonstra; Taroh Kinoshita; Shalini Jhangiani; Joep de Ligt; Frans P M Cremers; James R Lupski; Yoshiko Murakami; Bert B A de Vries
Journal:  Eur J Hum Genet       Date:  2015-03-25       Impact factor: 4.246

8.  Ophthalmic findings in an infant with phosphomannomutase deficiency.

Authors:  Wyatt B Messenger; Paul Yang; Mark E Pennesi
Journal:  Doc Ophthalmol       Date:  2014-02-04       Impact factor: 2.379

9.  Cyclic nucleotide-gated channel subunit glycosylation regulates matrix metalloproteinase-dependent changes in channel gating.

Authors:  Starla E Meighan; Peter C Meighan; Elizabeth D Rich; R Lane Brown; Michael D Varnum
Journal:  Biochemistry       Date:  2013-11-11       Impact factor: 3.162

10.  Electroretinography and Gene Expression Measures Implicate Phototransduction and Metabolic Shifts in Chick Myopia and Hyperopia Models.

Authors:  Nina Riddell; Melanie J Murphy; Sheila G Crewther
Journal:  Life (Basel)       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.